Shares of Carl Zeiss Meditec AG (ETR:AFX) have earned a consensus rating of “Hold” from the eight brokerages that are presently covering the firm, Marketbeat.com reports. Two analysts have rated the stock with a sell recommendation, five have given a hold recommendation and one has given a buy recommendation to the company. The average twelve-month price target among brokers that have updated their coverage on the stock in the last year is €81.19 ($94.40).
AFX has been the topic of several recent analyst reports. Berenberg Bank set a €14.00 ($16.28) price target on shares of Suedzucker and gave the company a “neutral” rating in a report on Wednesday. Independent Research set a €44.00 ($51.16) price target on shares of Brenntag and gave the company a “neutral” rating in a report on Wednesday. Hauck & Aufhaeuser set a €72.00 ($83.72) price target on shares of Stroeer SE & Co KGaA and gave the company a “buy” rating in a report on Monday, April 15th. Deutsche Bank lifted their price target on shares of Walmart from $118.00 to $120.00 and gave the company a “buy” rating in a report on Friday, May 17th. Finally, Nord/LB set a €8.50 ($9.88) price target on shares of Commerzbank and gave the company a “neutral” rating in a report on Wednesday, May 8th.
ETR:AFX traded down €0.40 ($0.47) during trading hours on Tuesday, hitting €97.50 ($113.37). The company had a trading volume of 110,757 shares, compared to its average volume of 94,405. The firm has a market cap of $8.72 billion and a P/E ratio of 67.99. The company’s 50-day simple moving average is €87.80. Carl Zeiss Meditec has a 52 week low of €60.25 ($70.06) and a 52 week high of €98.60 ($114.65). The company has a quick ratio of 3.09, a current ratio of 4.11 and a debt-to-equity ratio of 4.55.
Carl Zeiss Meditec AG operates as a medical technology company in Germany, the United States, Japan, other Europe countries, and internationally. It operates through two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers optical biometers, ophthalmic surgical microscopes, phacoemulsification/vitrectomy devices, intraocular lenses, and ophthalmic viscoelastic products for the diagnosis and treatment of ophthalmic diseases in the field of cataract and retinal surgery.
Featured Article: Why is momentum important to successful trading?
Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.